Sonnet BioTherapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Sonnet Biotherapeutics Holdings, Inc. |
| Form Type | 8-K |
| Filed Date | Dec 2, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
Sonnet BioTherapeutics filed an 8-K on Dec 2, 2025, with SEC updates.
AI Summary
Sonnet BioTherapeutics Holdings, Inc. filed an 8-K on December 2, 2025, reporting other events and financial statements. The company, formerly known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC, is incorporated in Delaware and headquartered in Princeton, NJ.
Why It Matters
This filing indicates that Sonnet BioTherapeutics is providing updates on its corporate activities and financial status to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports on significant corporate events or financial updates.
Key Numbers
- 001-35570 — Commission File Number (SEC filing identifier)
- 20-2932652 — IRS Employer Identification No. (Company tax identifier)
Key Players & Entities
- Sonnet BioTherapeutics Holdings, Inc. (company) — Registrant
- Chanticleer Holdings, Inc. (company) — Former company name
- TULVINE SYSTEMS INC (company) — Former company name
- December 2, 2025 (date) — Date of earliest event reported
- Princeton, NJ (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of December 2, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on December 2, 2025.
What are the former names of Sonnet BioTherapeutics Holdings, Inc.?
The company was formerly known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC.
Where are Sonnet BioTherapeutics Holdings, Inc.'s principal executive offices located?
The principal executive offices are located at 100 Overlook Center, Suite 102, Princeton, NJ 08540.
What is the Standard Industrial Classification code for Sonnet BioTherapeutics Holdings, Inc.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 420 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-12-02 09:25:31
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SONN The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 19KB
- 0001493152-25-025677.txt ( ) — 242KB
- sonn-20251202.xsd (EX-101.SCH) — 3KB
- sonn-20251202_lab.xml (EX-101.LAB) — 33KB
- sonn-20251202_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sonnet BioTherapeutics Holdings, Inc. December 2, 2025 By: /s/ Raghu Rao Name: Raghu Rao Title: Interim Chief Executive Officer